Morgan Stanley Raises NVIDIA Price Target to $200

Jul 30, 2025 Analyst: Joseph Moore 1 min read Reproduced verbatim
Rating
Buy
Price target
$200
from $170
Implied upside
+14%
vs $175.51 prior close
Morgan Stanley and NVIDIA logos

Morgan Stanley analyst Joseph Moore raised the price target on NVIDIA (NASDAQ: NVDA) to $200 (from $170) while maintaining an Overweight rating.

“We raise our 2026 MW EPS multiple from 28x to 33x, increasing our PT from $170 to $200 on $6.02 MW EPS.

We remain enthusiastic on the levels of aggregate demand for Blackwell as token growth continues to outpace what Nvidia can ship.

Supply bottlenecks will continue to set the pace of growth, but supply is set to improve in the second half, that should accelerate the momentum of EPS revisions. Remains out Top Pick in semis.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+36% NVDA $175.51 → $239.24 (Oct 7) · target reached

This call at 6 months✓ Target reached on Oct 28, 2025, 3 months after the note. At 12 months: reached.

Firm track recordMorgan Stanley reached 66% of its 53 scored targets within six months (#16 of 31 firms); on NVIDIA, 3 of 6. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.